NETRI est membre de Lyonbiopôle

General information

Batiment DomiLyon, 321 avenue Jean Jaurès

69007 Lyon

Incorporated in: 2018/06/11

Number of employees: 12


Main activity

NETRI develops technologies and microfluidic devices that accelerate the discovery and preclinical phases of a compound in development for pharmaceutical companies, CROs and university researchers interested in neurological disorders (Alzheimer's, Parkinson's, Huntington's). The company offers both Neurofluidics kits and Neuroscope Labs services to improve understanding of the structural and functional mechanisms of neurological disorders. The Neurofluidics devices use high throughput microfluidic devices to explore specific modes of action and provide rodent / human organ on chip disease models. Neuroscope Labs offer expertise services for rapid and reproducible data acquisition on a neurological compound. NETRI's unique expertise and patented microfluidic engineering technologies enable its solutions to be high throughput and physiologically relevant at the network level.


Looking for funding: Yes

Nature of funding searches: NETRI recherche des fonds pour développer ses activités de R&D et d'exploitation à l'internatioanl

Products / Services / Technologies

Strategic area of application
Medical Technologies

Application market
Neurological diseases

Therapeutics, Pharma or Biotech - CRO

Screening services - Design & Modelling studies - Disposable & Implants